Pharmaceutical combination of antiviral agents

Details Pharmaceutical combination of antiviral agents Pharmaceutical combination of antiviral agents

2005-05-03

2005-05-03

Travers, Russell (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S050000, C514S226200, C514S253010, C514S307000, C514S365000

Reexamination Certificate

active

06887879

ABSTRACT:
In accordance with the present invention there is provided a pharmaceutical combination useful for the treatment of viral infections comprising a at least one antiviral active compound of formula (1):and at least one further therapeutic agent chosen from nucleoside analogues; NNRTIs; and protease inhibitors.

REFERENCES:
patent: 4724232 (1988-02-01), Rideout et al.
patent: 5041449 (1991-08-01), Belleau et al.
patent: 5179104 (1993-01-01), Chu et al.
patent: 5270315 (1993-12-01), Belleau et al.
patent: 5276151 (1994-01-01), Liotta
patent: 5366972 (1994-11-01), Hargrave et al.
patent: 5444063 (1995-08-01), Schinazi
patent: 5684010 (1997-11-01), Schinazi
patent: 5767122 (1998-06-01), Chu et al.
patent: 5792773 (1998-08-01), Chu et al.
patent: 5830898 (1998-11-01), Schinazi et al.
patent: 5834474 (1998-11-01), Schinazi
patent: 5925643 (1999-07-01), Chu
patent: 631 786 (1989-10-01), None
patent: WO 9210497 (1992-06-01), None
Gulnik et al, Biochemistry, vol. 34, pp. 9282-9287.*
Chu et al, J. Org. Chem, vol. 56, pp. 6503-6505, 1991.*
Chen, Huachun et al. “Pharmacokinetics of (-)-β-D-2-Aminopurine Dioxolane and (-)-β-D-2-Amino -6-Chloropurine Dioxolane and Their Antiviral Metabolite (-)-β-D-Dioxolane Guanine in Rhesus Monkeys”Antimicrobial Agents and Chemotherapy, 40, 2332-2336 (1996).
Chen, Huachun et al. “Pharmacokinetics of (-)-β-D-Dioxolane Guanine and Prodrug (-)-βD- 2,6-Diaminopurine Dioxolane Following Intravenous Administration to Rats” manuscript submitted toAntimicrobial Agents&Chemo-therapy.
Chen, Huachun et al. “Pharmacokintecs of (-)-β-D-2,6-Diaminopurine Dioxolane and its Metabolite (-)-β-D-Dioxolane Guanine in Rhesus Monkeys” (Draft manuscript).
Good, Steven S et al. “Disposition in the Dog and the Rat of 2,6-Diamino-9-(2-Hydroxyethoxymethyl)Purine(A134U), a Potential Prodrug of Acyclovir”The Journal of Pharmacology and Experimental Therapeutics227, 644-651, USA.
Gu, Z. et al. “Mechanism of Action and In Vitro Activity of 1′,3′-Dioxolanylpurine Nucleoside Analogues against Sensitive and Drug-Resistant Human Immunodeficiency Virus Type 1 Variants,”Antimicrobial Agents and Chemotherapy, 43, 2376-2382 (1999).
Kim, H. O., et al., “Asymmetric Synthesis of 1,3-Dioxolane-Pyrimidine Nucleosides and Their Anti-HIV Activity”,Journal of Medicinal Chemistry, 1992, vol. 35, No. 11, pp. 1987-1992.
Kim, Hea O. et al. “1,3-Dioxolanylpurine Nucleosides (2R,4R) and (2R,4S) with Selective Anti-HIV-1 Activity in Human Lymphocytes”Journal of Medicinal Chemistry36, 30-37.
Kim, Hea O. et al. “L-β-(2S-4S)- and L-α-(2S,4R)-Dioxolanyl Nucleosides as Potential Anti-HIV Agents: Asymmetric Synthesis and Structure-Activity Relationships”Journal of Medicinal Chemistry36, 519-528.
Kim, Hea O. et al. Potent Anti-HIV and Anti-HBV Activities of (-)-L-β-Dioxolane-C and (+)-L-β-Dioxolane-T and Their Asymmetric Syntheses.Tetrahedron Letters, vol. 33, No. 46, pp. 6899-6902, 1992.
Norbeck, Daniel W. et al. “(±)-1-[(2β, 4β)-2-(Hydroxymethyl)-4-dioxolanyl]thymine) A new 2′,3′-Dideoxynucleoside Prototype with In Vitro Activity Against HIV” Tetrahedron Letters, 30, 6263-6266 (1989).
Schinazi, R. F. et al. “Developmenty of (-)-β-D-2,6-Diaminopurine Dioxolane as a Potential Antiviral Agent”,Antiviral Research, vol. 23, Supplement 1 (1994).
Spector, Thomas et al. “Conversion of 2,6-Diamino-9-(2-Hydroxyethoxymethyl) Purine to Acyclovir as Catalyzed by Adenosine Deaminase”Biochemical Pharmacologyvol. 32. No. 17, pp. 2505 2509, 1983 Great Britian.
Triangle Pharmaceuticals, website, “DAPD: A Potential Antiviral Purine Nucleoside Analogue,” site last updated on Feb. 5, 1999.
Gulnik et al., Biochemistry, vol. 34, pp. 9282-9287.

Affiliated with

Also associated with

Rating

Pharmaceutical combination of antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical combination of antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical combination of antiviral agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3371396